Washington Trust Advisors Inc. boosted its position in Neogen Co. (NASDAQ:NEOG – Free Report) by 10.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,966 shares of the company’s stock after buying an additional 1,100 shares during the period. Washington Trust Advisors Inc.’s holdings in Neogen were worth $241,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in NEOG. Steward Partners Investment Advisory LLC purchased a new stake in shares of Neogen during the first quarter worth $29,000. Point72 Hong Kong Ltd purchased a new stake in shares of Neogen in the first quarter worth $71,000. State of Tennessee Treasury Department purchased a new stake in shares of Neogen in the first quarter worth $45,000. International Assets Investment Management LLC purchased a new stake in shares of Neogen in the third quarter worth $49,000. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Neogen by 416.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,033 shares of the company’s stock worth $56,000 after buying an additional 2,446 shares in the last quarter. 96.73% of the stock is owned by institutional investors.
Neogen Price Performance
NEOG traded up $0.39 during trading on Thursday, reaching $15.85. The stock had a trading volume of 549,388 shares, compared to its average volume of 1,864,516. The business has a 50-day moving average of $16.32 and a 200-day moving average of $17.21. Neogen Co. has a one year low of $14.44 and a one year high of $24.09. The stock has a market cap of $3.43 billion, a PE ratio of 262.04 and a beta of 1.14. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.63 and a current ratio of 3.54.
Analysts Set New Price Targets
Separately, Piper Sandler increased their target price on Neogen from $17.50 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, January 18th.
Get Our Latest Stock Report on Neogen
About Neogen
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Featured Articles
- Five stocks we like better than Neogen
- Upcoming IPO Stock Lockup Period, Explained
- 3 Value Stocks Too Small For Buffett’s Portfolio
- How to Capture the Benefits of Dividend Increases
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Disney Stock Catches 3 Upgrades In a Single Week
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.